Login / Signup

Hepatitis delta virus infection prevalence, diagnosis and treatment in the Middle East: A scoping review.

Jeffrey Victor LazarusAhmad Al-RifaiFaisal M SanaiAbdullah Saeed AlghamdiAla I ShararaMotaz Fathy SaadLena van SelmSaleh A Alqahthani
Published in: Liver international : official journal of the International Association for the Study of the Liver (2022)
Hepatitis D virus (HDV) infection is a global public health concern, especially because of its unique existence in the presence of hepatitis B virus infection. HDV infection is estimated to affect 12 million people globally. Having a clearer understanding of its prevalence in all regions of the world is essential for helping direct preventive and early interventional treatment. This mini-review assessed the literature over the last 10 years to determine the prevalence, diagnostic means and treatment guidelines available for HDV in the Middle East. The search found limited data available in 21 articles, of which 18 were studies focused on Iran. Prevalence rates ranged dramatically among the countries, and none of the 12 countries included in the search had specific HDV guidelines. This review highlights the urgent need for more precise data for the Middle East region to help establish early diagnosis and treatment options for HDV.
Keyphrases
  • risk factors
  • public health
  • electronic health record
  • systematic review
  • big data
  • combination therapy
  • replacement therapy